Learn about our latest activities
December 29th, 2010 is a red-letter day, not only for NOVAST, but also for all Chinese pharmaceutical companies. LEVONEST™, developed by NOVAST, becomes the first Chinese-developed pharmaceutical product to be approved by the US FDA. With this approval, LEVONEST™ becomes the first “Made in China” prescription drug allowed to be exported into the USA.
NOVAST now has created a precedent of selling Chinese-manufactured products to the US and global markets. With this precedent, NOVAST has become a research-oriented, global pharmaceutical company.